July 9, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-6010
Legend Biotech Corporation
Request for Acceleration of Effective Date of Registration
Statement on Form F-3 (File No. 333-257625)
Ladies and Gentlemen:
Pursuant to Rule 461(a) of Regulation C under the Securities Act of 1933, as amended (the Securities Act), Legend Biotech Corporation (the Registrant) hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (Registration No. 333-257625) (the Registration Statement). The Registrant respectfully requests that, pursuant to Section 8(a) of the Securities Act of 1933, such Registration Statement be declared effective as of 2:00 p.m., Eastern Time, on Tuesday, July 13, 2021 or as soon as practicable thereafter.
The Registrant hereby authorizes Peter Devlin of Jones Day, counsel of the Registrant, to orally modify or withdraw this request for acceleration.
Please contact Peter Devlin at +1 (212) 326-3978 if you have any questions regarding this request and to provide notice of effectiveness.
|Legend Biotech Corporation|
|Name:||Ying Huang, Ph.D.|
|Title:||Chief Executive Officer and Chief Financial Officer|